Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

W Amy Schulman


  • Director at Arsanis Inc. (ASNS), 2017-12-01
  • Director at Alnylam Pharmaceuticals Inc. (ALNY), 2017-06-06
  • Director at Ironwood Pharmaceuticals Inc (IRWD), 2017-06-02
  • Director at Blue Buffalo Pet Products Inc. (BUFF), 2017-04-04
  • Director at Bind Therapeutics Inc (BIND), 2015-06-10
  • Former Exec. Vice President at Pfizer Inc (PFE), 2014-01-03
  • Director at Zoetis Inc. (ZTS), 2013-02-08
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
ZTS $26.00 5,000 Director 5,000 2013-02-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PFE $29.35 10,598 Officer 223,497 2013-05-15 Filing
PFE $29.41 10,408 Officer 234,095 2013-05-15 Filing
PFE $29.32 5,700 Officer 244,503 2013-05-15 Filing
PFE $29.34 5,268 Officer 250,203 2013-05-15 Filing
PFE $29.40 4,701 Officer 255,471 2013-05-15 Filing